DocGo Inc. Operating Lease, Payments
DocGo Inc. (DCGO) reported Operating Lease, Payments of $1.47 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-08-17
- DocGo Inc. operating lease, payments for the quarter ending 2026-06-30 was $1.47M, a 21.80% increase year-over-year.
- DocGo Inc. operating lease, payments for the quarter ending 2026-03-31 was $1.46M, a 36.62% increase year-over-year.
- DocGo Inc. operating lease, payments for the quarter ending 2025-12-31 was $1.44M, a 37.92% increase year-over-year.
- DocGo Inc. operating lease, payments for the quarter ending 2025-09-30 was $1.42M, a 59.37% increase year-over-year.
- DocGo Inc. operating lease, payments for fiscal 2025 was $5.13M, a 38.25% increase from fiscal 2024.
- DocGo Inc. operating lease, payments for fiscal 2024 was $3.71M, a 12.91% increase from fiscal 2023.
- DocGo Inc. operating lease, payments for fiscal 2023 was $3.29M, a 43.25% increase from fiscal 2022.
- DocGo Inc. operating lease, payments for fiscal 2022 was $2.29M, a 15.08% increase from fiscal 2021.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.47M 10-Q · filed 2026-08-17 | $2.93M 10-Q · filed 2026-08-17 | $4.37M derived: sum of 3 quarters · filed 2026-08-17 | $5.79M derived: sum of 4 quarters · filed 2026-08-17 |
| 2026-03-31 | $1.46M 10-Q · filed 2026-05-11 | $2.90M derived: sum of 2 quarters · filed 2026-05-11 | $4.32M derived: sum of 3 quarters · filed 2026-05-11 | $5.52M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-12-31 | $1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $2.86M derived: sum of 2 quarters · filed 2026-03-16 | $4.06M derived: sum of 3 quarters · filed 2026-08-17 | $5.13M 10-K · filed 2026-03-16 |
| 2025-09-30 | $1.42M 10-Q · filed 2025-11-10 | $2.62M derived: sum of 2 quarters · filed 2026-08-17 | $3.69M 10-Q · filed 2025-11-10 | $4.74M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-06-30 | $1.20M 10-Q · filed 2026-08-17 | $2.27M 10-Q · filed 2026-08-17 | $3.32M derived: sum of 3 quarters · filed 2026-08-17 | $4.21M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-03-31 | $1.07M 10-Q · filed 2026-05-11 | $2.11M derived: sum of 2 quarters · filed 2026-05-11 | $3.00M derived: sum of 3 quarters · filed 2026-05-11 | $3.85M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $1.93M derived: sum of 2 quarters · filed 2026-03-16 | $2.78M derived: sum of 3 quarters · filed 2026-03-16 | $3.71M 10-K · filed 2026-03-16 |
| 2024-09-30 | $890.74K 10-Q · filed 2025-11-10 | $1.74M derived: sum of 2 quarters · filed 2025-11-10 | $2.67M 10-Q · filed 2025-11-10 | $3.64M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-06-30 | $849.70K 10-Q · filed 2025-08-07 | $1.78M 10-Q · filed 2025-08-07 | $2.75M derived: sum of 3 quarters · filed 2026-03-16 | $3.44M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-03-31 | $928.99K 10-Q · filed 2025-05-08 | $1.90M derived: sum of 2 quarters · filed 2026-03-16 | $2.59M derived: sum of 3 quarters · filed 2026-03-16 | $3.46M derived: sum of 4 quarters · filed 2026-03-16 |
| 2023-12-31 | $967.84K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $1.66M derived: sum of 2 quarters · filed 2026-03-16 | $2.53M derived: sum of 3 quarters · filed 2026-03-16 | $3.29M 10-K · filed 2026-03-16 |
| 2023-09-30 | $697.05K 10-Q · filed 2024-11-07 | $1.56M derived: sum of 2 quarters · filed 2024-11-07 | $2.32M 10-Q · filed 2024-11-07 | $3.10M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $865.99K 10-Q · filed 2024-08-07 | $1.62M 10-Q · filed 2024-08-07 | $2.40M derived: sum of 3 quarters · filed 2025-02-27 | $3.03M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $756.25K 10-Q · filed 2024-05-08 | $1.53M derived: sum of 2 quarters · filed 2025-02-27 | $2.16M derived: sum of 3 quarters · filed 2025-02-27 | $2.59M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $777.10K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $1.40M derived: sum of 2 quarters · filed 2025-02-27 | $1.83M derived: sum of 3 quarters · filed 2025-02-27 | $2.29M 10-K · filed 2025-02-27 |
| 2022-09-30 | $626.19K 10-Q · filed 2023-11-06 | $1.05M derived: sum of 2 quarters · filed 2023-11-06 | $1.52M 10-Q · filed 2023-11-06 | $2.07M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $428.73K 10-Q · filed 2023-08-08 | $891.35K 10-Q · filed 2023-08-08 | $1.44M derived: sum of 3 quarters · filed 2024-02-28 | $1.96M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $462.63K 10-Q · filed 2022-05-10 | $1.01M derived: sum of 2 quarters · filed 2024-02-28 | $1.53M derived: sum of 3 quarters · filed 2024-02-28 | $1.98M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $547.92K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $1.07M derived: sum of 2 quarters · filed 2024-02-28 | $1.51M derived: sum of 3 quarters · filed 2024-02-28 | $1.99M 10-K · filed 2024-02-28 |
| 2021-09-30 | $519.72K 10-Q · filed 2022-11-08 | $966.28K derived: sum of 2 quarters · filed 2022-11-08 | $1.45M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $446.56K 10-Q · filed 2022-08-09 | $937.94K 10-Q · filed 2022-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |